AstraZeneca
AZN
#19
Rank
NZ$968.39 B
Marketcap
NZ$312.33
Share price
1.70%
Change (1 day)
28.70%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$9.08

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$8.91. In 2024 the company made an earnings per share (EPS) of NZ$7.56 an increase over its 2023 EPS that were of NZ$6.40.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$9.0820.02%
2024NZ$7.5618.23%
2023NZ$6.4081.13%
2022NZ$3.53631.03%
2021NZ$0.48-88.11%
2020NZ$4.07136.89%
2019NZ$1.72-39.41%
2018NZ$2.83-28.27%
2017NZ$3.95-14.37%
2016NZ$4.6124.11%
2015NZ$3.72127.55%
2014NZ$1.63-51.96%
2013NZ$3.40-58.95%
2012NZ$8.28-32.2%
2011NZ$12.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.39 95.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.26 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.87-67.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.42 50.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$34.19 283.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.17-30.73%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.31 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.65 41.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.95-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.99-32.79%๐Ÿ‡ฌ๐Ÿ‡ง UK